Research projects

Applications

Research Project

Human megakaryopoiesis

When the lab was founded our goal was to develop protocols for culturing human megakaryocytes

We started with umbilical cord blood which still represents our gold standard and then developed protocols for culturing megakaryocytes from human peripheral blood and bone marrow.

We recently reported (Di Buduo et al, TH 2020) a retrospective analysis of our 15-year experience in processing over 1,500 umbilical cord blood samples, with a focus on experimental procedures that are basic for a reproducible culture of functional megakaryocytes.

Steps of proplatelet formation in human megakaryopoiesis

Steps of proplatelet formation in human megakaryopoiesis

Research Project

Extracellular matrix components

One of the most abundant components of the bone marrow space, besides cells, is a variety of extracellular matrix components

On selective binding, this environment, in combination with soluble cytokines, regulates haematopoietic progenitor proliferation and differentiation. Haematopoietic progenitors develop as adherent cells in contact with extracellular matrix components in the bone marrow until they are released as non-adherent cells into the circulating blood.

Our lab has pursued for a long time the hypothesis that the interaction of megakaryocytes with bone marrow extracellular matrix components contributes to the regulation of megakaryocyte function. We have demonstrated that some collagen types can support proplatelet formation, while type I collagen is the only extracellular matrix environment that inhibits this process. Our recent evidence indicates that these differences may be ascribed to peculiar structural properties of the collagens, as well as to differences in receptor engagement.

In vivo, we have demonstrated that among bone marrow extracellular matrix components, fibronectin and type IV collagen are the most abundant around bone marrow sinusoids and constitute a peri-cellular matrix surrounding megakaryocytes. Megakaryocytes are able to express components of the basement membrane contributing to their regulation and to bone marrow homeostasis. The production of endogenous extracellular matrix components is significantly boosted in bone marrow regeneration following myelosuppression.

Collagen fibrils imaged by Atomic Force Microscopy

Collagen fibrils imaged by Atomic Force Microscopy

Spreaded megakaryocytes on collagen fibrils

Spreaded megakaryocytes on collagen fibrils

Megakaryocytes express different mechanosensors that contribute to platelet production by regulating the response to extracellular matrix environmental rigidity. Activation of transient receptor potential cation channel subfamily V member 4 (TRPV4), a mechano-sensitive ion channel, is induced upon megakaryocyte adhesion on softer matrices. This response promotes platelet production by triggering a cascade of events that lead to calcium influx, β1 integrin activation and internalization, and Akt phosphorylation, responses not found on stiffer matrices.

By Atomic Force Microscopy we have documented that the tensile strength of fibrils in type I collagen structure is a fundamental requirement to regulate cytoskeleton contractility of human megakaryocytes through activation of the Rho-ROCK pathway and MLC-2 phosphorylation.

Ongoing experiments focus on new mechanosensors, collagens, and fibronectin.

Back to top

Research Project

Soluble factors and megakaryocyte development

Soluble factors contribute to the regulation of megakaryocyte function in an autocrine manner both in physiology and disease

We have proven that Adenosine diphosphate, released by megakaryocytes, regulates proplatelet formation by interacting with P2Y13. The platelet count of patients with congenital delta-storage pool deficiency, who lack secretable adenosine diphosphate, is significantly lower than that of patients with other platelet function disorders.

Calcium spikes in human megakaryocytes

Calcium spikes in human megakaryocytes

We have proven the importance of calcium as a fundamental regulator of platelet production. The impact of calcium on megakaryocyte development was also studied in CALR-mutant Myeloproliferative Neoplasms demonstrating that a defective interaction between mutant calreticulin and SOCE proteins promotes megakaryocyte proliferation.

More experiments are ongoing to understand the exact role of calcium in regulating platelet formation in physiology and diseases.

Back to top

Research Project

Bone marrow 3D models and biomaterials

Millions of platelet transfusions are conducted each year, and the supply of this blood component is limited. There are many diseases where platelet production or function is impaired with severe consequences for patients.

We developed an innovative 3D system to study platelet production that represents the first spatial reconstruction of the bone marrow environment. In this system, human megakaryocytes were able to release functional platelets into vascular tubes.

We use silk fibroin, derived from Bombyx mori silkworm cocoons, as a natural biomaterial to build our models. The useful characteristics of this protein include self-assembly, robust mechanical properties, biocompatibility, and biodegradability. Together with low thrombogenicity, non-toxicity and low-immunogenicity, make this biomaterial a useful blood vessel substitute.

The combination of different bone marrow components and the compliance of silk-based structures makes this model a unique tool for the study of platelet formation and production for use in healthcare needs.

Silk as a biomaterial and silk based 3D bone marrow model.

Silk as a biomaterial and silk-based 3D bone marrow model.

Megakaryocytes releasing platelets in the 3D silk bone marrow

Megakaryocytes releasing platelets in the 3D silk bone marrow

Now, we are engineering a 3D printed platform that combines the use of silk and 3D printing technology to recreate the environment of the human bone marrow where platelets are produced. We believe that we can provide a sensitive system for ex-vivo screening of new therapeutic options on human megakaryocytes, thus leading to the choice of the best therapeutic course for patients’ clinical care (please go to the drug testing research project).

Back to top

Application

Megakaryopoiesis and pathology

Taking advantage of our novel protocol to derive megakaryocytes from peripheral blood, we have recently identified a series of quality and quantitative defects in a patient affected by inherited thrombocytopenias.

We described a defect of proplatelet formation involving tubulin distribution that affects megakaryocytes from patients with heterozygous Bolzano mutation and suggested that this abnormality contributes to their macrothrombocytopenia. We studied proplatelet formation by megakaryocytes carrying the MYH9-RD mutations, which were obtained by culture of patients’ blood progenitor cells. We demonstrated that two different MYH9 mutations cause a myosin-IIA loss-of-function, which results both in a defective regulation of proplatelet formation and in reduced complexity of proplatelet architecture. We propose that these alterations contribute to the thrombocytopenia of MYH9-RD.

Control (left) vs diseased (right) proplatelet forming megakaryocyte

Control (left) vs diseased (right) proplatelet forming megakaryocyte

Alterations in megakaryocyte function and proplatelet formation were also demonstrated in von Willebrand Type 2 disease, SLFN14-related thrombocytopenia, ANKRD26-related thrombocytopenia, ETV6-related thrombocytopenia, PTPRJ-related thrombocytopenia, and SRC-related thrombocytopenia.

Back to top

Application

Drug testing

Our silk platform also represents a novel screening technology in the pharmaceutical industry to predict the therapeutic effects of compounds on platelet number or function.

We started studying Thrombopoietin mimetic impact on megakaryocyte function showing a different mechanism of action of Romiplostim and Eltrombopag that may be relevant in clinical practice.

We demonstrated that increasing doses of Romiplostim (AMG531) determine a progressive increase of megakaryocyte proliferation with a parallel decrease in megakaryocyte ploidy and the capacity of extending proplatelets. While Eltrombopag favors human megakaryocyte differentiation and platelet production in a dose-dependent manner. These effects are determined by different phosphorylation of AKT and ERK1/2 signaling molecules, which have been proven to be crucial in regulating physiologic thrombopoiesis.

Back to top

Application

Myeloproliferative Neoplasms

We are searching the mechanisms of bone marrow fibrosis and megakaryocyte functional alterations in Myeloproliferative Neoplasms

Fibronectin

We identified the role of the fibronectin isoform EDA in regulating hemopoiesis in the bone marrow and demonstrated that this isoform is increased in patients with Primary Myelofibrosis both in the bone marrow and plasma, correlating with the fibrotic phase. We found that mice constitutively expressing the EDA domain (EIIIA+/+), but not EDA knockout mice, are more prone to develop BM fibrosis upon treatment with the thrombopoietin mimetic romiplostim (TPOhigh). Mechanistically, EDA FN binds to TLR4 and sustains progenitor cell proliferation and megakaryopoiesis in a TPO-independent fashion, inducing LPS-like responses, such as NF-κB activation and release of profibrotic IL-6.

Control (left) vs diseased (right) proplatelet forming megakaryocyte

Control (left) vs diseased (right) proplatelet forming megakaryocyte

Calcium

Approximately one-fourth of patients with essential thrombocythemia or primary myelofibrosis carry a somatic mutation of the calreticulin gene (CALR), the gene encoding for calreticulin. A 52-bp deletion (type I mutation) and a 5-bp insertion (type II mutation) are the most frequent genetic lesions. We studied the interaction between calreticulin and store-operated calcium (Ca2+) entry (SOCE) machinery in megakaryocytes from healthy individuals and from patients with CALR-mutated myeloproliferative neoplasms. In normal megakaryocytes, calreticulin regulates the activation of SOCE by interacting with ERp57 and STIM1. In CALR-mutated Myeloproliferative Neoplasms, defective interaction between mutant calreticulin and SOCE proteins promotes megakaryocyte proliferation.

Ongoing experiments are focused on calcium metabolism and the correlation between plasma EDA fibronectin and clinical features in Primary Myelofibrosis.